• Actavis Infringes Orexo's Long Term Zubsolv U.S. Patent ´330 americanpharmaceuticalreview
    January 14, 2019
    Orexo announces that the United States District Court for the District of Delaware has issued a final, non-appealable judgement that Actavis's generic Zubsolv products infringe Orexo's U.S. patent No. 8,940,330.....
PharmaSources Customer Service